The Skinny Label Crisis in Pharma Licensing: Innovation vs. Affordability
The Skinny Label Crisis in Pharma Licensing: Innovation vs. Affordability The “skinny label” strategy has emerged as a contentious battleground in pharmaceutical patent law, allowing generic manufacturers to launch products early by carving out patented uses from their FDA-approved labels under Section VIII of the Hatch-Waxman Act. This regulatory carve-out enables market entry for unpatented […]
Copyright Registration in Malaysia
Intellectual Property is a type of property that broadly speaking consists of creations of the mind. Briefly intellectual property can be further sub classified into patents, copyrights, trademarks, industrial designs and Geographical indications. Each of these categories refers to different sets of protection or rights that can be granted towards respective intellectual creations. These rights […]
Patent Lawsuit Against Stevia Suppliers
PureCircle USA, Inc. a subsidiary of PureCircle Ltd. and PureCircle, Sdn Bhd, which is based in Kuala Lumpur, Malaysia has filed a complaint in the U.S. District Court against Sweegen, Inc. claiming that Sweegen’s and Blue California’s Bestevia® are infringing its patent (U.S. Patent No. 9,243,273) which is a method for making Rebaudioside X (Reb-M) […]
Japanese Patent fund IP Bridge to raise $50m “Intellectual property and innovation” fund in Malaysia
On October 19, 2017, Japanese private equity fund “IP Bridge” disclosed its plan of launching a $50 million fund as a continuation of the ASEAN push for “Intellectual property and innovation” and signed an agreement with Malaysian local, Leonie Hill Capital (LCH) [1]. The agreement aims at investing in “IP rich or to-be-rich”, national and […]